Arcutis Biotherapeutics, Inc.
ARQT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $7 | -$16 | -$25 | -$11 |
| Dep. & Amort. | $1 | $0 | $3 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $10 | $10 | $10 | $9 |
| Change in WC | -$20 | $5 | -$18 | -$2 |
| Other Non-Cash | $0 | $0 | -$1 | $2 |
| Operating Cash Flow | -$2 | $0 | -$30 | -$1 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$1 | -$5 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$69 | -$33 | -$56 | -$17 |
| Inv. Sales/Matur. | $43 | $61 | $68 | $57 |
| Other Inv. Act. | $0 | -$10 | $0 | $0 |
| Investing Cash Flow | -$25 | $17 | $12 | $35 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $0 | -$97 |
| Financing Cash Flow | $1 | $1 | $0 | -$97 |
| Forex Effect | -$0 | $0 | $0 | -$0 |
| Net Chg. in Cash | -$26 | $19 | -$18 | -$64 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $73 | $54 | $72 | $135 |
| End Cash | $47 | $73 | $54 | $72 |
| Free Cash Flow | -$2 | $0 | -$31 | -$6 |